Technical Analysis for FBRX - Forte Biosciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.65 | 1.06% | 0.01 |
FBRX closed up 3.74 percent on Monday, March 18, 2024, on 41 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 29
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bullish Engulfing | Bullish | 1.06% | |
Stochastic Buy Signal | Bullish | 1.06% | |
Lower Bollinger Band Walk | Weakness | 1.06% | |
Lower Bollinger Band Touch | Weakness | 1.06% | |
Oversold Stochastic | Weakness | 1.06% | |
MACD Bearish Centerline Cross | Bearish | 4.84% | |
Lower Bollinger Band Walk | Weakness | 4.84% | |
Below Lower BB | Weakness | 4.84% | |
Lower Bollinger Band Touch | Weakness | 4.84% | |
Oversold Stochastic | Weakness | 4.84% |
Alert | Time |
---|---|
Up 1% | 8 minutes ago |
60 Minute Opening Range Breakout | about 22 hours ago |
Up 5% | about 22 hours ago |
Up 3% | about 24 hours ago |
Rose Above Lower Bollinger Band | about 24 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/29/2024
Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.2899 |
52 Week Low | 0.38 |
Average Volume | 36,059 |
200-Day Moving Average | 0.75 |
50-Day Moving Average | 0.69 |
20-Day Moving Average | 0.69 |
10-Day Moving Average | 0.69 |
Average True Range | 0.06 |
RSI (14) | 44.13 |
ADX | 14.89 |
+DI | 11.27 |
-DI | 19.85 |
Chandelier Exit (Long, 3 ATRs) | 0.61 |
Chandelier Exit (Short, 3 ATRs) | 0.78 |
Upper Bollinger Bands | 0.77 |
Lower Bollinger Band | 0.62 |
Percent B (%b) | 0.17 |
BandWidth | 21.60 |
MACD Line | -0.01 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0104 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.73 | ||||
Resistance 3 (R3) | 0.73 | 0.70 | 0.72 | ||
Resistance 2 (R2) | 0.70 | 0.68 | 0.70 | 0.71 | |
Resistance 1 (R1) | 0.67 | 0.66 | 0.69 | 0.67 | 0.71 |
Pivot Point | 0.64 | 0.64 | 0.65 | 0.64 | 0.64 |
Support 1 (S1) | 0.61 | 0.62 | 0.63 | 0.61 | 0.58 |
Support 2 (S2) | 0.58 | 0.60 | 0.58 | 0.57 | |
Support 3 (S3) | 0.55 | 0.58 | 0.57 | ||
Support 4 (S4) | 0.55 |